Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Boyer David W. sold 3,888 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 28, 2026
On May 26, 2026, Boyer David W. (Chief Corp. Affairs Officer) sold 3,888 Neurocrine Biosciences, Inc. shares at US$156.64 for US$609K under a trading plan, leaving 7,799 shares. Filed May 28, 2026 (Form 4).
- Sold
- 3,888 shares
- Price
- US$156.64
- Value
- US$609K
- Holding after
- 7,799 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Corp. Affairs Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Sale | 3,888 | US$156.64 | 7,799 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Boyer David W.
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Boyer David W. · Sep 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026
- Form 4 · Lippoldt Darin · Sep 15, 2026